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Cryptococcal Meningitis
A CASE TREATED WITH 5-FLUOROCYTOSINE
555
E. W. VAN DEN ENDE, J. A. HAMMOND, R. L. AMOILS
SUMMARY
Cryptococcal meningitis occurred in an elderly Coloured
woman in the Northern Cape. She presented with symp-
toms and signs suggestive of encephalitis 4 weeks after
a cholecystectomy. After the administration of cortisone,
cryptococcal organisms were isolated in her cerebrospinal
fluid. She was first treated with intravenous amphotericin-B
without improvement, and then with 5-f1uorocytosine
orally, to which she responded without appreciable side-
effects. An abdominal gland biopsy suggested sarcoidosis,
but sarcoid reaction may occur in the presence of crypto-
coccosis, although the organisms could not be demon-
strated, as is often the case.
S. Afr. Med. l., 48, 555 (1974).
CASE mSTORY
A 65-year-old Coloured woman had been complaining of
intermittent nausea and vomiting, with no relation to
meals, for more than a year. On examination in July 1972
she was found to have mobile glands in the left supra-
clavicular fossa, both axillae and both groins. Her liver
was palpable with a firm regular edge.
Investigations
Her haemoglobin level was 14,1 g/IOO ml; white cell
count 5OO0/mm'; erythrocyte sedimentation rate 6 mm/
hour (Westergren). The radiograph of the chest was nor-
mal. A cholecystogram demonstrated a non-functioning
gall bladder. At laparotomy gall stones were found, as
well as large fleshy glands around the porta hepatis and
along the lesser curvature of the stomach. A biopsy
specimen was taken and the histology was reported to
how non-specific inflammatory changes. Her postoperative
recovery was uneventful.
Four weeks later the patient presented at another
hospital with severe headache, mild neck stiffness and
fever. A lumbar puncture showed protein 80 mgflOO ml;
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sugar 80 mg/100 ml; lymphocytes 4/mm3 ; polymorphs
I/mm'; chlorides 670 mg/100 ml. A diagnosis of encepha-
litis was made and with the persistence of symptoms,
cortisone was added to her treatment. A repeat lumbar
puncture was performed after a worsening of her clinical
condition, with the following results: protein 300 mg/100
ml; polymorphs 23/mm3 ; lymphocytes 6/mm'; sugar nil;
chlorides 650 mgjlOO ml. Her cerebrospinal fluid pressure
was raised at this stage.
She was transferred to Kimberely Hospital in September
1972. Her complaints were severe headache, weakness of
all limbs, and pain in her neck. On examination she was
mentally depressed with neck stiffness, and reflexes were
generally decreased, but there were no localising signs
nor nerve involvement. No papilloedema was present and
the chest and rest of the examination were normal. Her
temperature was 38°C.
Further Investigations
A lumbar puncture showed a raised cerebrospinal fluid
pressure, protein 295 mg/loo ml; sugar 29,5 mgjIOO ml;
chlorides 670 mg/IOO ml; polymorphs 400/mm'; lympho-
cytes 125/mm3 ; erythrocytes lOO/mm'. On direct micro-
scopy of the cerebrospinal fluid, encapsulated yeast cells
resembling Cryptococcus neoformans were seen, and
confirmed with India ink stain and on culture. Further
investigations were as follows: haemoglobin 14,8 g/100 ml;
white cell count 15200/mm3 ; erythrocyte sedimentation
rate 31 mm/h (Westergren): urea 33 mg/!oo ml;
uric acid 3,9 mg/lOO ml; creatinine 0,9 mg/lOO ml; electro-
lytes: potassium 3,9 mEq/litre; sodium 136 mEq/litre;
chlorides 102 mEq/litre; blood sugar 90 mg/IOO ml; serum
calcium I1 mg/IOO ml.
An infusion of amphotericin-B was started. She re-
mained acutely ill without change in pyrexia or clinical
condition and, after 10 days, treatment was commenced
with 5-fluorocytosine as a supply of this drug had become
available. Her temperature was normal within 5 days and
a repeat lumbar puncture showed protein 175 mgjIoo ml;
sugar 40 mg/IOO ml; chlorides 720 mg/IOO ml; polymorphs
26/mm3 ; lymphocytes 289/mm3• After 2 weeks she was
asymptomatic. On review of the histology of the previous
abdominal gland biopsy, a diagnosis of sarcoidosis was
made. The cerebrospinal fluid returned virtually to normal
within 6 weeks, and 6 months after completion of treat-
ment she remained well with normal cerebrospinal fluid
values (Fig. 1).
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Fig. 1. Chart of laboratory findings and therapy, including cerebrospinal fluid, cell
counts (L = Iymphocytes; P = polymorphs, e = erythrocytes), blood urea, uric
acid, and periods of treatment with amphotericin-B and 5-ftuorocytosine.
DISCUSSION
Cryptococcosis is a highly fatal infection caused by
Cryptococcus neoformans, an encapsulated yeast with a
special predilection for the central nervous system. The
possibility of underlying Hodgkin's disease, lymphosar-
coma, leukemia or diabetes should be considered in everv
patient with cryptococcosis, as it occurs with increased
frequency in such patients.' The granulomatous inflamma-
tory reaction produced. by Cryptococcus neoformans,
especially in the lymph nodes and bone, may contain
typical non-caseating tubercles just as are seen in the
sarcoid reaction. When the organisms cannot be identified,
as is often the case in tissue sections, it may be impossible
to distinguish between the two di'eases.' Boeck's sarcoidosis
and cryptococcosis seldom coexist.s.• The demonstration
of a sarcoid reaction in our patient's gland biopsy is most
probably due to Cryptococcus neoformans, although or-
ganisms were not demonstrated on histology. It seems
probable that isolation of C. neoformans after steroid
therapy was due to an exacerbation as a result of the,
cortisone therapy. In the Mississippi Valley, where torulosis
is endemic, hydrocortisone (lOO mg intravenously) is
used as a provocative test in cases of obscure chronic
meningitis:
Until 1957 there was no successful treatment for most
cases of cryptococcosis. Cryptococcal meningitis was al-
most always fatal. The introduction of amphotericin-B re-
duced the mortality of cryptococcal meningitis from above
90% in the first year to 25% over 3 years. Intravenous
administration (up to 1 mg/kg/day until 3 g is given) and
intrathecal administration (0,025 mg increasing to 0,5 mg
daily) are recommended. Severe side-effects may occur
including idiosyncratic reactions and impaired renal func-
tion. The latter occurs in 80% of treated cases although
permanent renal damage can usually be prevented by
reducing the dose.' In this patient, amphotericin-B was
discontinued after 10 days as she showed no response to
intravenous administration.
5-Fluorocytosine represents an important advance in the
chemotherapy of cryptococcosis and some serious fungal
diseases, especially systemic moniliasis.' 5-Fluorocytosine
is reported to be an antimetabolite of cytosine in
C. neoformans, Candida albicans and other fun"i but
apparently not in man. It is effectiv~ in reducing ~;owth
in these fungi but has no antibacterial effect.5 5-Fluorocy-
tosine is administered orally in a dose of 200 mg/kg/day in
4 divided doses and continued for 6 weeks. After this
period the maintenance dose should be 100 mg/kg/day.s
The drug is excreted mainly by the kidneys and has a
wide margin of safety; potentially toxic high plasma levels
follow normal dosage regimens in patients with renal
insufficiency. The drug is distributed widely in the body
and not bound to plasma proteins. Evidence was obtained
that 5-fluorocytosine is excreted by filtration at glomerular
level without significant tubular reabsorption or secretion.
No evidence was obtained that 5-fluorocytosine is' de-
aminated to 5-fluoro-uracil after administration by this
route. Cerebrospinal fluid concentration of the dru" is
almost equal to blood levels.' b
We wish to thank Roche Products (Pty) Ltd, for data and
the supply of 5-f1uorocytosine.
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